ClinicalTrials.gg
Not yet recruitingNCT06713018Updated Dec 3, 2024

Orthopedic Intelligent Navigation System in the Treatment of Fresh Femoral Neck Fractures

An interventional study of Three cannulated compression screws by navigation system and Traditional three cannulated compression screws in Fracture of Neck of Femur, sponsored by Chinese PLA General Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-03.

Sponsored by Chinese PLA General Hospital · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Femoral Neck Fractures with a site in China — 7 open to participants now, 7 under way, none of them phase 3. Femoral Neck Fractures · China.

Planned enrollment
5th of 20
300 · median 118
Started
2024
with 3 others
No phase
18 of 22
5 open now
Registered
16th of 22
by date
Lead sponsor
4 of 22
Chinese PLA General Hospital

Among the 22 studies in Femoral Neck Fractures with a site in China, this one is the 5th largest by planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2024, is one of 18 with no phase, and was the 16th registered.

Femoral Neck Fractures

207 studies on the registry are indexed under Femoral Neck Fractures; 40 are open to participants now.

Browse Femoral Neck Fractures studies →

Open to participants now

7 of the 22 studies in Femoral Neck Fractures with a site in China are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 23 Femoral Neck Fractures studies recruiting now, 16 (70%) set no upper age limit and 4 (17%) stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Femoral Neck Fractures with a site in China, or all of them as a file.
02

Study summary

The goal of this clinical trial is to verify the safety and effectiveness of orthopaedic surgical navigation system in the treatment of fresh femoral neck fractures.

Participants will:

  • Take three cannulated compression screws by navigation system or by traditional method to treat femoral neck fractures.
  • Visit the clinic 1, 3, 6, 12 months after surgery for checkups and tests.
03

Conditions studied

  • Fracture of Neck of Femur

Keywords

  • orthopedic intelligent navigation system
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥18 years old, gender is not limited;
  2. Patients diagnosed with femoral neck fracture;
  3. Patients with indications for internal fixation of femoral neck fracture and able to tolerate surgery;
  4. The subject or his legal representative is informed of the nature of the study and agrees to participate in the study.

Exclusion criteria

Exclusion Criteria:

  1. Participants who had participated in clinical studies of other drugs, biologics or medical devices before enrollment and did not reach the primary study endpoint time limit;
  2. The patient is known to have a history of allergy to one or more implanted materials;
  3. Patients determined by researchers to be physically weak or unable to tolerate surgery due to other systemic diseases;
  4. Active infection of the hip joint or other parts of the body is determined by the investigator;
  5. Diagnosed as metabolic bone disease, radiation bone disease, etc.;
  6. Severe hip contracture deformity or severe muscle loss fused to the functional position for a long time without pain;
  7. have inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.;
  8. The patient is mentally incapable or unable to understand the requirements of participating in the study, and it is difficult to cooperate;
  9. Other conditions deemed unsuitable for inclusion by the investigator.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Three cannulated compression screws by navigation system

    Procedure: Three cannulated compression screws by navigation system

  • Placebo comparator
    Traditional three cannulated compression screws

    Procedure: Traditional three cannulated compression screws

Interventions

  • ProcedureThree cannulated compression screws by navigation system

    Patients with femoral neck fractures treated with three cannulated compression screws assisted by a navigation system

  • ProcedureTraditional three cannulated compression screws

    Patients with femoral neck fractures treated with traditional three cannulated compression screws

06

What researchers measure

Primary outcomes

  1. Perspective frequency

    Document the total number of intraoperative fluoroscopy sessions taken during surgery, including each anteroposterior and lateral fluoroscopic image

    Time frame: 1 day

Secondary outcomes

  1. Neck shaft angle

    Time frame: 1 year

  2. Guide needle implantation effect

    For the group treated with three hollow compression screws, the effect of the implantation of guide pins is categorized into three parallel pins, two parallel pins, and mutually non-parallel pins, with measurements taken during the surgery.

    Time frame: 1 day

  3. Fluoroscopy times of needle implantation

    Time frame: 1 day

  4. Operation time

    Time frame: 1 day

  5. Operative blood loss

    Time frame: 1 day

  6. Fracture union

    Postoperative follow-up observation is conducted for all patients, with anteroposterior and lateral hip X-rays taken at the 1st, 3rd, 6th, and 12th postoperative months. X ray and CT scans are reviewed at the 1st and 3rd postoperative months to observe the stability of the implanted internal fixation, the disappearance of the fracture line, and whether there is displacement of the fracture ends.

    Time frame: 1 year

  7. Zarit Burden Interview score

    The Zarit Burden Interview (ZBI) is a commonly used assessment tool designed to quantify the psychological and emotional burden experienced by caregivers who provide care for individuals with cognitive or functional impairments. Developed by Zarit and colleagues, the scale consists of 22 items that cover various aspects of caregiver burden, such as time pressure, emotional strain, and social isolation. The scoring ranges from 0 to 88, with higher scores indicating a greater level of caregiving burden. This tool aids healthcare professionals in identifying the psychological stress faced by caregivers and provides appropriate support and interventions to improve their mental health and quality of life.

    Time frame: 1 year

  8. Harris score

    The Harris Score (Harris Hip Score, HHS) is a widely used scale for evaluating hip joint function and patient quality of life, often applied to assess the outcomes of hip replacement surgery or other treatments for hip joint diseases. It covers four main aspects: pain level, functional activity, joint range of motion, and hip joint deformity. The total score ranges from 0 to 100, with 100 being the best possible condition, indicating complete normalcy of hip joint function.

    Time frame: 1 year

  9. SF-36 score

    The SF-36 (Short Form 36 Health Survey) is a widely used generic health status assessment tool developed by the Medical Outcomes Study (MOS) Group. The scale is designed to comprehensively evaluate health-related quality of life, encompassing eight dimensions: physical functioning, social functioning, role limitations due to physical health, role limitations due to emotional problems, bodily pain, mental health, vitality, and general health perceptions. Each dimension consists of several items, and scores are derived by summing the scores of these items, typically converted to a 0 to 100 percent scale, with 100 representing the best possible health state. These eight dimension scores can be combined to form two summary scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS).

    Time frame: 1 year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2024; primary completion for Oct 2026, 22 months later.

Of 63 non-industry interventional studies with no phase under Femoral Neck Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 62. This study's planned 22 months is below that.

Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 25 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2024
First posted
Dec 3, 2024
StartEst.
Dec 10, 2024
Primary completionEst.
Oct 31, 2026
CompletionEst.
Oct 31, 2026
Last update
Dec 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06713018
Responsible party
Zhang Wei (Deputy head of orthopedics, Chinese PLA General Hospital) — Principal investigator
First posted
Dec 3, 2024
Start date
Dec 10, 2024 (estimated)
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Dec 3, 2024

Study contacts

Wei Zhang
Contact
bszw@hotmail.com
+8612409252

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion